Cargando…

Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity

The great advances in the studies on metal complexes for the treatment of different cancer forms, starting from the pioneering works on platinum derivatives, have fostered an increasingly growing interest in their properties and biomedical applications. Among the various metal-containing drugs inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riccardi, Claudia, Musumeci, Domenica, Trifuoggi, Marco, Irace, Carlo, Paduano, Luigi, Montesarchio, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958509/ https://www.ncbi.nlm.nih.gov/pubmed/31561546 http://dx.doi.org/10.3390/ph12040146

Ejemplares similares

Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity
por: Piccolo, Marialuisa, et al.
Publicado: (2021)

Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study
por: Riccardi, Claudia, et al.
Publicado: (2023)

Design, Synthesis, and Characterization of an Amphiphilic Lipoic Acid-Based Ru(III) Complex as a Versatile Tool for the Functionalization of Different Nanosystems
por: Riccardi, Claudia, et al.
Publicado: (2023)

Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem
por: Ferraro, Maria Grazia, et al.
Publicado: (2023)

Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
por: Irace, Carlo, et al.
Publicado: (2017)

Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
por: Ferraro, Maria Grazia, et al.
Publicado: (2020)

Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
por: Piccolo, Marialuisa, et al.
Publicado: (2019)

Assessing the role of membrane lipids in the action of ruthenium(III) anticancer compounds
por: Starosta, Radoslaw, et al.
Publicado: (2023)

Disentangling the Structure–Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs
por: Platella, Chiara, et al.
Publicado: (2021)

Novel Unsymmetrical Ru(III) and Mixed-valence Ru(III)/Ru(II) Dinuclear Compounds Related to the Antimetastatic Ru(III) Drug NAMI-A
por: Serli, B., et al.
Publicado: (2001)

Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
por: Masternak, Joanna, et al.
Publicado: (2020)

G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents
por: Musumeci, Domenica, et al.
Publicado: (2015)

New Nanostructured Materials Based on Mesoporous Silica Loaded with Ru(II)/Ru(III) Complexes with Anticancer and Antimicrobial Properties
por: Marinescu, Gabriela, et al.
Publicado: (2023)

A new ion imprinted polymer based on Ru(III)-thiobarbituric acid complex for solid phase extraction of ruthenium(III) prior to its determination by ETAAS
por: Zambrzycka, Elżbieta, et al.
Publicado: (2014)

Synthesis, Antiproliferative Activity, and DNA Binding Studies of Nucleoamino Acid-Containing Pt(II) Complexes
por: Riccardi, Claudia, et al.
Publicado: (2020)

Synthesis, Characterization, Anticancer, and Antioxidant Studies of Ru(III) Complexes of Monobasic Tridentate Schiff Bases
por: Ejidike, Ikechukwu P., et al.
Publicado: (2016)

Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells
por: Dalla Pozza, Maria, et al.
Publicado: (2021)

Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition
por: Riccardi, Claudia, et al.
Publicado: (2020)

Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity
por: Elsayed, Shadia A., et al.
Publicado: (2020)

Analysis of the First Spectrum of Ruthenium (Ru I)
por: Kessler, K. G.
Publicado: (1959)

Ru(III) Complexes with Lonidamine-Modified Ligands
por: Shutkov, Ilya A., et al.
Publicado: (2021)

Updates on the anticancer potential of garlic organosulfur compounds and their nanoformulations: Plant therapeutics in cancer management
por: Pandey, Pratibha, et al.
Publicado: (2023)

Cytotoxic (salen)ruthenium(iii) anticancer complexes exhibit different modes of cell death directed by axial ligands
por: Li, Cai, et al.
Publicado: (2017)

Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics
por: Musumeci, Domenica, et al.
Publicado: (2017)

Affinity Chromatography‐Based Assays for the Screening of Potential Ligands Selective for G‐Quadruplex Structures
por: Platella, Chiara, et al.
Publicado: (2022)

Solvolysis of the Tumor-Inhibiting Ru(III)-Complex trans-Tetrachlorobis(Indazole)Ruthenate(III)
por: Pieper, Thomas, et al.
Publicado: (2000)

Binding of Antitumor Ruthenium(III) Complexes to Plasma Proteins
por: Messori, L., et al.
Publicado: (2000)

Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine
por: Kljun, Jakob, et al.
Publicado: (2010)

Antimetastatic activity of novel ruthenium (III) pyridine complexes
por: Gu, Liwei, et al.
Publicado: (2016)

Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one!
por: Moccia, Federica, et al.
Publicado: (2019)

Synthesis of a Cholesteryl-HEG Phosphoramidite Derivative and Its Application to Lipid-conjugates of the Anti-HIV (5')TGGGAG(3') Hotoda’s Sequence
por: Musumeci, Domenica, et al.
Publicado: (2012)

Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies
por: Kaps, Anna, et al.
Publicado: (2021)

G-quadruplex-based aptamers against protein targets in therapy and diagnostics()
por: Platella, Chiara, et al.
Publicado: (2017)

Tetra-μ-acetato-κ(8) O:O′-bis[(3-cyanopyridine-κN (1))ruthenium(II,III)](Ru—Ru) hexafluoridophosphate 1,2-dichloroethane monosolvate
por: Minaker, Samuel A., et al.
Publicado: (2011)

Supplementary Zeeman Data for the First Spectrum of Ruthenium (Ru I)
por: McNally, J. Rand, et al.
Publicado: (1959)

Tuning the Polymorphism of the Anti-VEGF G-rich V7t1 Aptamer by Covalent Dimeric Constructs
por: Riccardi, Claudia, et al.
Publicado: (2020)

Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures
por: Criscuolo, Andrea, et al.
Publicado: (2022)

Catalytic Hydrolysis of Tricresyl Phosphate by Ruthenium (III) Hydroxide and Iron (III) Hydroxide towards Sensing Application
por: Zhou, Lang, et al.
Publicado: (2020)

Tetra-μ-acetato-κ(8) O:O′-bis[(3-chloropyridine-κN)ruthenium(II,III)](Ru—Ru) hexafluoridophosphate 1,2-dichloroethane monosolvate
por: Aquino, Anthony J., et al.
Publicado: (2022)

Synthesis and Assessment of Antibacterial Activities of Ruthenium(III) Mixed Ligand Complexes Containing 1,10-Phenanthroline and Guanide
por: Abebe, Atakilt, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rc1m4mdjv4t6lcb13op8lvvhga